[Hepatitis non-A, non-B-associated substance in stool from patients with posttransfusion and sporadic hepatitis]. 1988

R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
Institut für Immunologie und Experimentelle Pathologie GmbH, Karlsruhe.

A hepatitis non-A,non-B-associated substance (HNANB-AS) excreted in feces has been detected by means of a sandwich radioimmunoassay using reconvalescent serum and IgG from patients with posttransfusion HNANB. 4380 stool filtrates from 1599 patients were screened with this assay. In patients with posttransfusion or sporadic acute and chronic HNANB the substance was detected with a mean frequency of 34%, in acute posttransfusion HNANB, where samples were screened at the beginning of the clinical symptoms, 71.4% of stool specimens were positive for HNANB-AS. A high frequency of positive results was found in patients undergoing dialysis (31.3%), hemophiliacs (16.6%) and patients with cryptogenic cirrhosis (16%). Positive specimens were seen in hepatitis A (7.1%), acute and chronic HBV-infection (9.6%), various liver diseases (7.8%), outpatients of a physician (3.1%) and clinical or laboratory staff (6%). In these groups, too, anamnestic data speaking in favour for a possible HNANB frequently were obtained. The discovery of a partially double-stranded circular DNA of 5.0 Kb in HNANB-AS which sequence differs from human, bacterial and known viral DNA, argues the presence of a viral particle in stools of patients with sporadic and parenteral HNANB.

UI MeSH Term Description Entries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D065227 Transfusion Reaction Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. Delayed Hemolytic Transfusion Reaction,Acute Hemolytic Transfusion Reaction,Blood Transfusion-Associated Adverse Reactions,Delayed Serologic Transfusion Reaction,Febrile Non-Hemolytic Transfusion Reaction,Hemolytic Transfusion Reaction,Hypotensive Transfusion Reaction,Post-Transfusion Purpura,Posttransfusion Purpura,TAGHD,Transfusion-Associated Allergic Reaction,Transfusion-Associated Circulatory Overload,Transfusion-Associated Dyspnea,Transfusion-Associated Graft Vs. Host Disease,Transfusion-Transmitted Infection,Allergic Reaction, Transfusion-Associated,Blood Transfusion Associated Adverse Reactions,Circulatory Overload, Transfusion-Associated,Circulatory Overloads, Transfusion-Associated,Dyspnea, Transfusion-Associated,Febrile Non Hemolytic Transfusion Reaction,Hemolytic Transfusion Reactions,Infection, Transfusion-Transmitted,Post Transfusion Purpura,Posttransfusion Purpuras,Purpura, Post-Transfusion,Purpura, Posttransfusion,Reaction, Hemolytic Transfusion,Reaction, Hypotensive Transfusion,Reactions, Hemolytic Transfusion,Transfusion Associated Allergic Reaction,Transfusion Associated Circulatory Overload,Transfusion Associated Dyspnea,Transfusion Associated Graft Vs. Host Disease,Transfusion Reaction, Hemolytic,Transfusion Reaction, Hypotensive,Transfusion Reactions,Transfusion Reactions, Hemolytic,Transfusion Reactions, Hypotensive,Transfusion Transmitted Infection,Transfusion-Associated Circulatory Overloads,Transfusion-Transmitted Infections

Related Publications

R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
December 1994, Journal of virology,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
August 1994, Journal of hepatology,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
September 1988, Annals of internal medicine,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
July 1991, Journal of medical virology,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
January 1985, Progress in clinical and biological research,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
March 1993, Hepatology (Baltimore, Md.),
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
May 1985, Gastroenterology,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
April 1985, Liver,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
August 1990, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
R Seelig, and H Liehr, and E Wildhirt, and R Ringelmann, and M Hilfenhaus, and P M Reisert, and J Reitinger, and J Burckhardt, and H P Seelig
October 1984, The American journal of gastroenterology,
Copied contents to your clipboard!